Skip to main content

Advertisement

Log in

Use and cost of skin biopsy procedures in the Medicare Part B fee-for-service population, 2017 to 2020

  • SHORT REPORT
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

The data that support the findings of this study are openly available in Medicare Part B Physician Supplier Procedure Summary Master Files at https://data.cms.gov/summary-statistics-on-use-andpayments/physiciansupplier-procedure-summary.

References

  1. Coldiron B, Ratnarathorn M (2014) Scope of physician procedures independently billed by mid-level providers in the office setting. JAMA Dermatol 150(11):1153–1159. https://doi.org/10.1001/jamadermatol.2014.1773

    Article  PubMed  Google Scholar 

  2. Gronbeck C, Feng H (2021) Volume and distribution of skin biopsies performed by dermatologists and other health care providers in the Medicare population in 2019. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2021.11.006

    Article  PubMed  Google Scholar 

  3. Kircik LH (2019) A closer look at the new biopsy codes. Cutis 103(3):122–123

    PubMed  Google Scholar 

  4. Patel S, Nguyen BT (2021) Characterization of biopsies by dermatologists and nonphysician providers in the Medicare population: a rapidly changing landscape. Dermatol Surg 47:1337–1341. https://doi.org/10.1097/dss.0000000000003150

    Article  CAS  PubMed  Google Scholar 

  5. US Centers for Medicare & Medicaid Services. Medicare provider utilization and payment data: physician and other supplier public use file. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Physician-and-Other-Supplier.html. Accessed 8 Mar 2023.

Download references

Funding

Dr. Yeung is supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases under award number K23 AR075888 and L30 AR076081. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Duszak is a medical advisor and shareholder in Ethos Medical, Inc. During this study, he received related research funding from the Harvey L. Neiman Health Policy Institute.

Author information

Authors and Affiliations

Authors

Contributions

All authors made substantial contributions to conception and design, acquisition of data, and analysis and interpretation of data, been involved in drafting the manuscript, and revised it critically for important intellectual content and gave final approval of the version to be published. All authors agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Howa Yeung.

Ethics declarations

Conflict of interest

None declared.

Ethical approval

Exempt.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Blalock, T., Duszak, R. et al. Use and cost of skin biopsy procedures in the Medicare Part B fee-for-service population, 2017 to 2020. Arch Dermatol Res 315, 2437–2439 (2023). https://doi.org/10.1007/s00403-023-02618-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-023-02618-1

Navigation